Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

By Steven G. Deeks, T. Wrin, T. Liegler, R. Hoh, M. Hayden, Jason D. Barbour, N. Hellmann, Christos J. Petropoulos, J. McCune, M. Hellerstein and 1 more. New England Journal of Medicine, 2001

718 citations recorded by the source corpus.

Subfields: Emergency Medicine, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/165dbd2db474b64d16d6674d7c0759c5b60ddccd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Thompson
2. M. Saag
3. S. Hammer
4. D. Cooper
5. D. Richman
6. D. M. Jacobsen
7. P. Volberding
8. R. Schooley

Citations in the corpus

• Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. (2002, background): “detected following withdrawal of the drugs.(122) However, resistance mutations archived at the cell level may per-”
• History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens (2005, neutral): “(2001), Deeks et al. (2002), Deeks et al.”